Filing Flows › Lifeward (LFWD) › R&D spending
Lifeward (LFWD) R&D spending by quarter
Lifeward's R&D spending was $1.8M in Q2 2026 (second quarter 2026), -70% from Q1 2026. Over the last 7 quarters it ranged from $721K (Q3 2025) to $5.8M (Q1 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $1.8M | -70% | +129% |
| Q1 2026 | $5.8M | +593% | +537% |
| Q4 2025 | $843K | +17% | -25% |
| Q3 2025 | $721K | -6% | — |
| Q2 2025 | $767K | -16% | — |
| Q1 2025 | $918K | -19% | — |
| Q4 2024 | $1.1M | — | — |
Q2 2026 at a glance
Lifeward, Q2 2026: revenue $6.6M (+16% year over year), operating margin -62.7%, net loss $11.5M, operating cash flow −$6.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Lifeward's R&D spending?
Lifeward's R&D spending was $1.8M in Q2 2026 (second quarter 2026), -70% from Q1 2026.
How has Lifeward's R&D spending changed?
Over the last 7 quarters it ranged from $721K (Q3 2025) to $5.8M (Q1 2026).